{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:15:36Z","timestamp":1791584136117,"version":"4.3.4"},"reference-count":26,"publisher":"Wiley","license":[{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Evidence-Based Complementary and Alternative Medicine"],"published-print":{"date-parts":[[2021,11,11]]},"abstract":"<jats:p>Background. As a traditional Chinese medicine tonic, Buzhong Yiqi decoction has the effects of invigorating Qi and lifting Yang. In this study, the effects of Buzhong Yiqi Shenge decoction combined with THP bladder perfusion on postoperative efficacy in bladder cancer were investigated. Methods. A total of 70 cases of bladder cancer patients were divided into the experimental group and control group according to the random number table method, with 35 cases in each group. The control group was treated with THP bladder perfusion. The experimental group was treated with Buzhong Yiqi Shenge decoction on the basis of the control group. The number of urine white blood cells, VEGF level, the incidence of adverse reactions, and KPS score were compared between the two groups before and after treatment. Results. After 3 and 6 months of therapy, the KPS score of the experimental group increased significantly compared with the control group. However, after 12 months of treatment, there was no difference in KPS scores between the two groups. Moreover, there was no significant variation in serum VEGF between two groups after 3 months of treatment. However, Buzhong Yiqi decoction notably reduced the level of VEGF after 6 months and 12 months. After 3 months, the urine white blood cell count was lower in the experimental group than in the control group. After 6 and 12 months, there was no difference in urine white blood cell count between the two groups. Furthermore, a total of 14 patients in two groups had reoccurrence after one year. Our results showed that there was no significant difference in postoperative recurrence rate between the experimental group and the control group. The occurrence rates of frequent and urgent urination, nausea\/loss, and abnormal urine routine of appetite in the experimental group were significantly lower than those in the control group. But there was no difference in the occurrence rate of low heat, hematuria between the experimental group and the control group. Conclusion. Buzhong Yiqi decoction combined with THP bladder perfusion has no advantage in the short-term recurrence rate of bladder cancer patients. However, Buzhong Yiqi decoction can alleviate the symptoms of adverse reactions and improve the quality of life of patients.<\/jats:p>","DOI":"10.1155\/2021\/3685213","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T18:35:08Z","timestamp":1636655708000},"page":"1-6","source":"Crossref","is-referenced-by-count":11,"title":["Effects of Buzhong Yiqi Decoction Combined with THP Bladder Perfusion on Postoperative Efficacy in Patients with Bladder Cancer"],"prefix":"10.1155","volume":"2021","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1900-3693","authenticated-orcid":true,"given":"Yunfeng","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Chengyang People\u2019s Hospital, Qingdao 266109, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4163-191X","authenticated-orcid":true,"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nutriology, Qingdao Hospital of Traditional Chinese Medicine, Qingdao Hiser Hospital, Qingdao 266033, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6124-4592","authenticated-orcid":true,"given":"Zhongguo","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Urology Surgery, Qingdao Central Hospital, Qingdao University, Qingdao 266033, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2028-646X","authenticated-orcid":true,"given":"Qiuying","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Imaging, Zhangqiu District People\u2019s Hospital, Jinan 250200, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8385-2572","authenticated-orcid":true,"given":"Huijing","family":"Jin","sequence":"additional","affiliation":[{"name":"Ward Department, Zhangqiu District People\u2019s Hospital, Jinan 250200, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29210"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-00313-1"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07655-x"},{"issue":"4","key":"5","first-page":"1652","article-title":"Efficacy of bladder perfusion of alternating hydroxycamptothecin and gemcitabine combined with low-dose tuberculin in the treatment of non-muscle invasive bladder cancer after TURBT","volume":"24","author":"L. Chen","year":"2019","journal-title":"Journal of B.U.ON: Official Journal of the Balkan Union of Oncology"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1111\/iju.14548"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2020.03.009"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108899"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222875"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.capr-19-0093"},{"issue":"6","key":"11","first-page":"186","article-title":"Progress in TCM treatment of bladder cancer","volume":"5","author":"R. Zhou","year":"2018","journal-title":"Journal of Clinical Medical"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111044"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6882-14-488"},{"issue":"4","key":"14","first-page":"354","article-title":"Toxicity attenuation and efficacy potentiation effects of sijunzi decoction on bladder carcinoma treated by chemotherapy in mice","volume":"25","author":"C. Li","year":"2005","journal-title":"Chinese Journal of Integrated Traditional and Western Medicine"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050175"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1080\/13880209.2019.1626449"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18081616"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.3892\/or.2017.5570"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4278"},{"issue":"S2","key":"20","first-page":"234","article-title":"Bladder perfusion THP combined oral compound fufang fufangteng mixture in bladder cancer TURBT postoperative clinical curative effect observation","volume":"23","author":"J. Zhou","year":"2016","journal-title":"Chinese Journal of Cancer Prevention and Treatment"},{"issue":"12","key":"21","first-page":"110","article-title":"Effect of Xiaozheng decoction combined with hydroxycamptothecin bladder instillation on postoperative recurrence of bladder tumor and serum VEGF","volume":"16","author":"B. Liu","year":"2018","journal-title":"Oncology Progress"},{"key":"22"},{"issue":"21","key":"23","first-page":"2530","article-title":"Regulation of three Jianpi Buqi recipes on intestinal microflora of Piqi-deficiency rat","volume":"33","author":"Y. Peng","year":"2008","journal-title":"China Journal of Chinese Materia Medica"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1016\/s0047-6374(00)00249-9"},{"issue":"10","key":"25","first-page":"1869","article-title":"Effect of Buzhong Yiqi decoction on PI3K and AKT in spleen, stomach and lung of nude mice with lung adenocarcinoma transplantation tumor","volume":"39","author":"Y. Liu","year":"2014","journal-title":"China Journal of Chinese Materia Medica"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.4268\/cjcmm20110430"}],"container-title":["Evidence-Based Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/ecam\/2021\/3685213.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/ecam\/2021\/3685213.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/ecam\/2021\/3685213.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T18:35:20Z","timestamp":1636655720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/ecam\/2021\/3685213\/"}},"subtitle":[],"editor":[{"given":"Nadeem","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,11,11]]},"references-count":26,"alternative-id":["3685213","3685213"],"URL":"https:\/\/doi.org\/10.1155\/2021\/3685213","relation":{},"ISSN":["1741-4288","1741-427X"],"issn-type":[{"value":"1741-4288","type":"electronic"},{"value":"1741-427X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,11]]}}}